These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma. Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224 [TBL] [Abstract][Full Text] [Related]
23. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871 [TBL] [Abstract][Full Text] [Related]
24. Comparison of indirect immunofluorescence and line immunoassay for autoantibody detection. Jeon YL; Kim MH; Lee WI; Kang SY Clin Exp Rheumatol; 2013; 31(1):84-90. PubMed ID: 23043859 [TBL] [Abstract][Full Text] [Related]
25. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets. Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683 [TBL] [Abstract][Full Text] [Related]
26. Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies. De Lorenzo R; Pinal-Fernandez I; Huang W; Albayda J; Tiniakou E; Johnson C; Milisenda JC; Casal-Dominguez M; Corse AM; Danoff SK; Christopher-Stine L; Paik JJ; Mammen AL Neurology; 2018 Jun; 90(23):e2068-e2076. PubMed ID: 29728522 [TBL] [Abstract][Full Text] [Related]
27. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects]. Eymard B Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270 [TBL] [Abstract][Full Text] [Related]
28. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621 [TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Pluk H; van Hoeve BJ; van Dooren SH; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJ Ann Neurol; 2013 Mar; 73(3):397-407. PubMed ID: 23460448 [TBL] [Abstract][Full Text] [Related]
30. [Sporadic Inclusion Body Myositis and Autoantibodies]. Yamashita S; Ando Y Brain Nerve; 2018 Apr; 70(4):449-457. PubMed ID: 29632292 [TBL] [Abstract][Full Text] [Related]
31. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398 [TBL] [Abstract][Full Text] [Related]
32. Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement. Goyal NA; Cash TM; Alam U; Enam S; Tierney P; Araujo N; Mozaffar FH; Pestronk A; Mozaffar T J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):373-8. PubMed ID: 25857661 [TBL] [Abstract][Full Text] [Related]
33. Mortality in autoimmune rheumatic diseases with anti-Ro/SSA antibody in Korea: Single center-based retrospective study. Kim SK; Choe JY; Kwak SG Int J Rheum Dis; 2019 Feb; 22(2):191-199. PubMed ID: 30398019 [TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires. Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700 [TBL] [Abstract][Full Text] [Related]
35. Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases. Chiang HL; Tung CH; Huang KY; Hsu BB; Wu CH; Hsu CW; Lu MC; Lai NS Medicine (Baltimore); 2021 Sep; 100(37):e27230. PubMed ID: 34664863 [TBL] [Abstract][Full Text] [Related]
36. Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52. Yamasaki Y; Satoh M; Mizushima M; Okazaki T; Nagafuchi H; Ooka S; Shibata T; Nakano H; Ogawa H; Azuma K; Maeda A; Tonooka K; Ito H; Takakuwa Y; Inoue M; Mitomi H; Kiyokawa T; Tsuchida K; Matsushita H; Mikage H; Murakami Y; Chan JY; Ozaki S; Yamada H Mod Rheumatol; 2016; 26(3):403-9. PubMed ID: 26344678 [TBL] [Abstract][Full Text] [Related]
38. Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis. Chung SH; Bent EI; Weiss MD; Gardner GC Clin Rheumatol; 2021 Oct; 40(10):4089-4094. PubMed ID: 33884496 [TBL] [Abstract][Full Text] [Related]
39. Pathomechanisms of anti-cytosolic 5'-nucleotidase 1A autoantibodies in sporadic inclusion body myositis. Tawara N; Yamashita S; Zhang X; Korogi M; Zhang Z; Doki T; Matsuo Y; Nakane S; Maeda Y; Sugie K; Suzuki N; Aoki M; Ando Y Ann Neurol; 2017 Apr; 81(4):512-525. PubMed ID: 28318044 [TBL] [Abstract][Full Text] [Related]
40. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]